 Home > Medical News >

Medical Research Articles

Hengrui PharmaceuticalS SHR6390 approved clinical lying for the treatment of recurrent or metastatic breast cancer

 Time of Update: 2020-06-07

sglt 2 inhibitors cathode positive negative 2 4 dnp stage 2 leukemia cancer diagnostics inc

yesterday, it was revealed that Hengrui Medicine (http:// SHR6390 tablets approved for clinical use in the combination of fluorovis group treatment HR-positive, HER2-negative after endocrine thera
European Commission approves two options for treating HNSCC patients in Mercadon Keytruda

 Time of Update: 2020-06-07

carcinoma axid generic name aripiprazole generic name namzaric generic name nanotechnology cancer treatment

recently, Mersadon announced that the European Commission (EC) has approved two options for Keytruda (Corida, generic name: pembrolizumab, Pablozumab), a first-line treatment of patients with metast
Takeda releases latest data on phase 3 clinical trials of the quadnage dengue vaccine TAK-003

 Time of Update: 2020-06-07

flu vaccine effectiveness type 1 water ind clinical trial typhim vi vaccine www seesaw com

recently, Takeda company (http:// released the latest data from its quadrat dengue vaccine, TAK-003, in the key phase 3 clinical trial (http:// TIDES THE OVERALL VACCINE EFFICACY (VE) OF TAK-
Xcovery's ALK inhibitor ensartinib (X-396) Phase 2 clinical trial yields positive results

 Time of Update: 2020-06-07

a hair 1 2 butadiene new china covington 1 2 ghz herpes 1 2

recently, Xcovery (http:// announced that its ALK inhibitor ensartinib (X-396) had positive results in the treatment of alK-positive non-small cell lung cancer (NSCLC) patients in the phase 2 cli
Kadmon's key trial of oral selective ROCK2 inhibitor KD025 reached the main endpoint

 Time of Update: 2020-06-07

lyme disease test cells immune system immune system cells corticosteroids albendazole 200 mg

today, Kadmon announced that its use in the treatment of chronic transplant anti-host disease (cGVHD) in the study of oral selective ROCK2 inhibitor KD025, in the critical test (http:// ROCKstar
Uber reaches primary and secondary endpoints in the study of IL-17A/F single anti-drug bimekizuma in key Phase 3 trials

 Time of Update: 2020-06-07

whats 1 3 ocean surface area hpv type 16 iga deficiency treatment human cell lines

recently, UCB announced that bimekizumab, the (http:// of the substance IL-17A/F mono-anti- drug for the treatment of chronic moderate to severe plaqueps (plaquepsis), had reached two common prim
Lilly IL-17 inhibitor Taltz (ixekizumab) two clinical trials reach primary and secondary endpoint

 Time of Update: 2020-06-07

anti vitamin anti inflammatory anti dna antibody cell signaling pathway 2 3 dibromobutane

today, Eli Lilly (http:// announced that its IL-17 inhibitor Taltz (ixekizumab) has reached its primary and all critical secondary in two clinical trials (http:// treating patients with active
FDA U.S. Approves APR APR-TD011 Research Drug for Large Herpes Epidermis to Be Certified as Orphan Drug

 Time of Update: 2020-06-07

vitamins wound healing infection treatment physical properties quartz fda government agency what 1 3

Recently, the (http:// of the Research of the Pharmaceutical (http:// of the Swiss APR Applied Pharmaceutical s (http:// announced that the U.S Food and Medicines (http:// Administration (
Voclosporin with mycophenolic acid and low-dose steroids in combination with the treatment of lupus nephritis key 3-phase bed trial struck positive results

 Time of Update: 2020-06-07

remeron drug class solve 2 3 global control fentanyl drug class 1 2 7 8

recently, Aurinia Pharmaceuticals (http:// announced that the company's development of voclosporin, in combination with mycophenolic acid (MM) and low-dose steroids, reached all major and critica
Yan Jian and Alkermes jointly developed Vumerity (diroximel fumarate) with provisional FDA approval

 Time of Update: 2020-06-07

avobenzone side effects resveratrol side effects gas drug drug digest diphenhydramine drug test

recently, Biogen and Alkermes company (http:// to develop a new recurrent type of multiple sclerosis (MS) new treatment, Vumerity (diroximel fumarate), received provisional approval for the FDA
China's State Drug Administration approves application for new drug ® by Astellas Acostin

 Time of Update: 2020-06-07

benadryl drug t4 total high lamictal drug interactions high dose probiotics norco drug class

Today, the http:// Group of the Pharmaceuticals (http:// announced that china's national Drug (http:// Supervisory Authority on November 18 approved the listing of the (http:// ) of the of
Trovagene PLK1 inhibitor onvansertib (PCM-075) obtains positive early trial data

 Time of Update: 2020-06-07

kras g12c mutation viral gene therapy selective catalytic reduction pd 1 inhibitor acute blood loss

today, Trovagene (http:// announced that it had obtained positive experimental early data in the treatment of 1b/2 clinical trial strial sin (http:// ) in patients with metastatic colorectal ca
Seattle's oral small molecule tyrosine kinase inhibitor tucatinib Phase 3 trial reaches primary and secondary endpoints

 Time of Update: 2020-06-07

progesterone positive breast cancer parkinson's treatment drug factor 9 solid phase brain eating disease

today, Seattle Genetics (http:// announced that its HER-specific oral small molecule tyrosine kinase inhibitor tucatinib, in the treatment of HER2-positive metastatic breast cancer patients in th
GSK developed the triavement of chronic obstructive pulmonary disease Trelegy Ellipta approved by the National Drug Administration for listing

 Time of Update: 2020-06-07

ibuprofen anti inflammatory onion anti inflammatory still's disease treatment history celiac disease a cabinets

Recently, GSK developed the chronic obstructive pulmonary disease (COPD) tri-therapy fluorobutikason ume bromoquine Verantro inhalation powder mist agent (Trelegy Ellipta) approved by the State Drug
FDA approves Novartis Adakveo (crizanlizumab, also known as SEG101) for listing

 Time of Update: 2020-06-07

abundant white blood cell terlipressin fda approval phentermine fda approved mitosis cancer cells 2 white pill

recently, Novartis (http:// announced that the U.S FDA (http:// approved the launch of its potential heavy-duty therapy, Adaklizumab, also known as SEG101, to reduce the frequency of vascular
Baxter Squibb CC-486 Maintenance Therapy Treats AML Patients In Phase 3 Key Trials Get Positive Results

 Time of Update: 2020-06-07

malaria treatment japanese hair treatment telomerase cancer cells stormwater treatment atg treatment

today, The (http:// of Baxter's Squibb Company announced that its CC-486, as a maintenance therapy, achieved a statistically significant improvement in total survival (OS) and non-recurrent survi
MHLW approves Alexion's Soliris (eculizumab) for a new indication

 Time of Update: 2020-06-07

supplements fda approved curcumin drug interactions zoloft drug benadryl drug test topamax drug class

Recently, Alexion company (http:// announced that the Ministry of Health, Labour and Welfare (MHLW) has approved a new indication of Soliris (eculizumab) for the treatment of anti-water channel p
Zhengda Tianqing anti-tumor drug injection with hydrochloric acid benzostin has been issued by the State Drug Administration drug registration approval

 Time of Update: 2020-06-07

eddp drug azo drug biology group topiramate drug class group streptococcus

recently, China Bio Pharmaceutical (http:// issued a notice that affiliated company (http:// Zhengda Tianqing Pharmaceutical Group, the anti-tumor drug injection with hydrochloric acid benzodi
Phase Libtayo clinical trials developed by Regenerative Element and Sanofi show good results

 Time of Update: 2020-06-07

1 3 cyclohexanedione clinical trials glioblastoma libtayo fda approval united states industries monoclonal gammopathy treatment

Regeneron company (http:// recently announced that its PD-1 inhibitor Libalo,developed with Sanofi, as a single-drug therapy, has shown significantly better results in the first-stage treatment o
Inovio announces that its INO-5401 combination therapy extends progression-free survival in Phase 1/2 clinical trials treating GBM

 Time of Update: 2020-06-07

clinical trial regulation stage 2 thyroid cancer cea pancreatic cancer serous ovarian cancer treatment data

Today, Inovio Pharmaceuticals (http:// announced that it is working on T-cell activation immunotherapy INO-5401, which is composed of immunoactive agent INO-9012, Libtayo (cemiplimab) Combined th

Go to Page

Medical Research Articles

Hengrui PharmaceuticalS SHR6390 approved clinical lying for the treatment of recurrent or metastatic breast cancer

European Commission approves two options for treating HNSCC patients in Mercadon Keytruda

Takeda releases latest data on phase 3 clinical trials of the quadnage dengue vaccine TAK-003

Xcovery's ALK inhibitor ensartinib (X-396) Phase 2 clinical trial yields positive results

Kadmon's key trial of oral selective ROCK2 inhibitor KD025 reached the main endpoint

Uber reaches primary and secondary endpoints in the study of IL-17A/F single anti-drug bimekizuma in key Phase 3 trials

Lilly IL-17 inhibitor Taltz (ixekizumab) two clinical trials reach primary and secondary endpoint

FDA U.S. Approves APR APR-TD011 Research Drug for Large Herpes Epidermis to Be Certified as Orphan Drug

Voclosporin with mycophenolic acid and low-dose steroids in combination with the treatment of lupus nephritis key 3-phase bed trial struck positive results

Yan Jian and Alkermes jointly developed Vumerity (diroximel fumarate) with provisional FDA approval

China's State Drug Administration approves application for new drug ® by Astellas Acostin

Trovagene PLK1 inhibitor onvansertib (PCM-075) obtains positive early trial data

Seattle's oral small molecule tyrosine kinase inhibitor tucatinib Phase 3 trial reaches primary and secondary endpoints

GSK developed the triavement of chronic obstructive pulmonary disease Trelegy Ellipta approved by the National Drug Administration for listing

FDA approves Novartis Adakveo (crizanlizumab, also known as SEG101) for listing

Baxter Squibb CC-486 Maintenance Therapy Treats AML Patients In Phase 3 Key Trials Get Positive Results

MHLW approves Alexion's Soliris (eculizumab) for a new indication

Zhengda Tianqing anti-tumor drug injection with hydrochloric acid benzostin has been issued by the State Drug Administration drug registration approval

Phase Libtayo clinical trials developed by Regenerative Element and Sanofi show good results

Inovio announces that its INO-5401 combination therapy extends progression-free survival in Phase 1/2 clinical trials treating GBM